BEAMSTART Logo

FDA struggles to catch up on drug inspections, raising worries about safety of US drug supply

Business Mirror LogoBusiness Mirror16h ago

FDA struggles to catch up on drug inspections, raising worries about safety of US drug supply - Business Mirror

Quick Summary:

WASHINGTON—Federal regulators responsible for the safety of the US drug supply are still struggling to get back to where they were in 2019, before the Covid-19 pandemic upended factory inspections in the US and across the world, The Associated Press has found.

Most of the overdue plants are in the US, but more than 340 are in India and China, countries that together make up the largest source of drug ingredients used in low-cost US prescriptions.“Generic drugmakers are under intense pressure to cut their costs and some will do that by cutting quality,” said David Ridley of Duke University, who studies the pharmaceutical industry.“If they’re not inspected, then we won’t know about it until—in a few tragic cases—it’s too late.

The firms that are overdue for safety and quality inspections represent about 42 percent of the 4,700 plants that are currently registered to produce drugs for the US and previously underwent FDA review before May 2019, the AP found.


More Pictures

FDA struggles to catch up on drug inspections, raising worries about safety of US drug supply - Business Mirror (Picture 1)

or

Article Details

Author / Journalist: BusinessMirror

Category: BusinessStartups

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-09-07 @ 16:05:00 (16 hours ago)

News Timezone: GMT +8:00

News Source URL: businessmirror.com.ph

Language: English

Article Length: 2065 words

Reading Time: 12 minutes read

Sentences: 71 lines

Sentence Length: 30 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Mirror

News ID: 22398899

View Article Analysis

About Business Mirror

Business Mirror Logo

Main Topics: BusinessStartups

Official Website: businessmirror.com.ph

Update Frequency: 19 posts per day

Year Established: 2005

Headquarters: Philippines

News Last Updated: 16 hours ago

Coverage Areas: Philippines

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Local / Regional

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #37

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "FDA struggles to catch up on drug inspections, raising worries about safety of US drug supply" has 2065 words across 71 sentences, which will take approximately 9 - 18 minutes for the average person to read.

Which news outlet covered this story?

The story "FDA struggles to catch up on drug inspections, raising worries about safety of US drug supply" was covered 16 hours ago by Business Mirror, a news publisher based in Philippines.

How trustworthy is 'Business Mirror' news outlet?

Business Mirror is a fully independent (privately-owned) news outlet established in 2005 that covers mostly business and startups news.

The outlet is headquartered in Philippines and publishes an average of 19 news stories per day.

It's most recent story was published 16 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #22398899
  • URL: https://beamstart.com/news/fda-struggles-to-catch-up-17257276309287

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.